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NZB mice spontaneously develop autoimmune diseases (1). This fact has prompted 
extensive studies of all aspects of their immune system. Among other phenomena, it 
was found that stimulation of normal NZB lymphocytes in vitro with H-2-identical 
BALB/c or DBA/2  lymphocytes readily induced cytotoxic T  cell responses (2, 3). We 
(4)  and others (5)  have shown that this primary in vitro response is directed against 
antigens of the Tla region, where NZB mice differ from other H-2  d strains (6). In the 
course of that study,  we observed that when primed NZB  lymphocytes were restim- 
ulated with BALB/c cells in vitro, they became cytotoxic to target cells of all strains 
tested, with the exception of NZB.  Here we analyze the specificity of this secondary 
response. Whereas the response itself is a normal T  cell response to an antigen present 
in nearly all other strains but missing in NZB, the antigen is unusual. 
Materials and Methods 
Mice.  Adult mice of both sexes were obtained from the sources listed in Table I. The NZB/ 
Icr ×  C58/J (NX8) recombinant inbred strains were established and maintained at the Institute 
for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pa. by brother-sister mating for 
>20 generations (7). 
F1 hybrids between  NZB/Icr and  BALB/c or C58/J were bred at the Institute for Cancer 
Research;  (SJL  ×  NZB/FiiII)F~ and  (A.CA  X  NZB/CrBom)Fa  hybrids  and  first  generation 
backcross  progeny  to NZB/CrBom were bred  at  the Basel  Institute  for Immunology,  Basel, 
Switzerland. 
Tumor  Cells.  The  following  tumor  target  cell  lines  were  kindly  given  to  us  by  Dr.  R. 
MacDonald,  Ludwig Institute  for Cancer  Research,  Lausanne,  Switzerland:  P815,  a  DBA/2 
mastocytoma; EL4, a C57BL/6 lymphoma; AKR-A, a spontaneous AKR thymoma; and YAC- 
1, an A/Sn Moloney leukemia virus-induced lymphoma. They were all maintained in vitro. 
Immunizations.  Donors of responding cells were given a  single (or occasionally two, at least 
3 wk apart)  intraperitoneal  injection of 2 ×  107 spleen cells, washed and suspended  in serum- 
free medium. 
Generation and Assay  of CTL.  Spleen cells from normal or immunized donors, taken at least 
2  wk  after  priming,  were  stimulated  by  coculture  with  irradiated  or  mitomycin  C-treated 
allogeneic spleen cells for 5 d  (4).  Their cytotoxic activity was assayed on ~lCr-labeled target 
cells stimulated  2  or  3  d  before with  lipopolysaccharide  (LPS) 1 or concanavalin  A  (ConA), 
respectively (4, 8). The spontaneous release in the 3.5-h assay ranged from  12.3 to 44.3% of the 
maximum, with a  median of 22.0% for 97 targets. 
* Supported by grants AI-13797, CA-09035, CA-06927,  RR-05539,  and by an appropriation from the 
Commonwealth of Pennsylvania. 
:~ Institute for Cancer Research, Fox Chase Cancer Center, Philadelphia, Pa. 
i Abbreviations used in this paper: C', complement; ConA, concanavalin A; LPS, lipopolysaccharide;  N, 
NZB/Icr; PHA, phytohemagglutinin; RI, recombinant inbred; 8, C58/J. 
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TABLE  I 
Mouse Strains  Typed for Mta 
Strain  H-2*  Qed- 1  *  Method:]:  Source§ 
Negative 
NZB/BINJ  d  a  1  Jax 
NZB/CrBom  d  a  1  Born 
NZB/Icr  d  ~.  1  Icr 
NZB/Hz  d  a  1  Icr 
NMRI  ?  a  l  Born 
Positive 
B6. Tla  '~  b  a  1  Frill 
BALB.B  b  b  1  B.B., Olac 
C57BL/6  b  b  1  Frill 
C57BL/10SeCr  b  b  1  Bom 
C57L/J  b  b  2  Jax 
C3H.SW  b  b  1  Icr 
LP/J  b  b  1  Jax 
BALB/c  d  b  1  Frill, Bom, Icr 
DBA/2  d  b  1  Frill 
NZB/Frill  d  a  1  Frill 
NZB/BIPt  d  a  1  Pt 
A.CA  f  a'  1  Frill 
B10.M  f  a'  3  Frill 
B 10.BR  k  a  3  Olae, Jax 
C58/J  k  a  1  Jax, Ier 
AKR/J  k  b  1  Jax 
BALB.K  k  b  2  C.B. 
CBA/J  k  b  1  Frill, Bom 
C3H/HeJ  k  b  1  Icr 
C3H/Tif  k  b  1  Bom 
B10.Y  pa  a  3  Jax 
BUB/BNJ  q  a  1  Jax 
SWR  q  a  1  B & K 
RIIIS/J  r  c  1  Jax 
SJL  s  a  1  Frill, Bom, Ier 
PL/J  u  a  1  Jax 
* H-2 types from reference (6), Qed-I types from reference (4) and recent, unpublished data 
(K. Fischer Lindahl). 
:]: 1, cold target inhibition of Mta-specific lysis;  2, direct lysis by NZB/CrBom primed and 
restimulated with NZB/FfiI1;  3, direct lysis by NZB/CrBOM  primed with BALB/c and 
restimulated with DBA/2. 
§ B.B., Dr. B. Blomberg, Basel Institute for Immunology; B & K, Bantin and Kingman Ltd., 
The Field Station, Grimston, Aldborough, Hull, England; Born, GI. Bomholtgaard Ltd., 
Ry, Denmark; C.B., Dr. C. Berek, Basel Institute for immunology, Basel, Switzerland; Frill, 
Institut frir Biologiseh-Medizinisehe Forschung AG, Fiillinsdorf, Switzerland; Icr, Institute 
for  Cancer  Research,  Fox  Chase  Cancer  Center,  Philadelphia,  Pa.;  Jax,  The Jackson 
Laboratory,  Bar  Harbor,  Maine;  Olac,  Olac  Ltd.,  Shaw's Farm,  Blackthorn,  Bicester, 
Oxon, England; Pt, Dr. M. Potter, National Cancer Institute, Bethesda, Md. 
The percent specific 5aCr-release was calculated  from  the geometric means  (8)  of triplicate 
determinations as: 
(mean experimental release -  mean spontaneous release) 
x  100. 
(mean maximal release -  mean spontaneous release) 
The average SD of 2,800 sets of triplicates amounted to 8.2% of the respective means. K.  FISCHER  LINDAHL, M.  BOCGHIERI, AND R.  RIBLET  1585 
Cold  target  inhibition  was  carried  out  in  round-bottomed  microtiter plates;  each  well 
contained 1 X 104 51Gr-labeled target cells, 3 X 106 cold target cells, and effector cells generated 
from 3 x  I0  s responder cells (8). Maximal inhibition is to be expected with the specific target 
as cold target inhibitor; minimal inhibition should be observed with the responder itself as cold 
inhibitor. The degrees of lysis were always evaluated in terms of these two controls. With the 
number of combinations to be assayed, it was not feasible to test killers and inhibitors in several 
ratios. Thus, depending on the efficiency of the killers, revealed only by the assay, the reduction 
of lysis with a fixed number of effective inhibitors could therefore be complete or intermediate 
(cf. the two anti-H-2  d killers in Fig. 5) or occasionally barely significant (of. the anti-H-2  k killers 
in Fig. 4). All experiments have been done at least twice, giving the same typing results. 
T  Cell Enrichment and Depletion.  Spleen  (and occasionally lymph node)  cells were passed 
through nylon-wool columns (9) or columns of glass beads coated with mouse immunoglobulin 
(Ig)  and  rabbit  anti-mouse Ig (10).  The  percentage of Ig-positive cells in  the effluent  was 
determined by indirect immunofluoreseent staining (4).  T  cells were removed by treatment 
with a monoclonal anti-Thy-l.2 antibody, F7D5 (a generous gift from Dr. P. Lake, University 
College, London), and complement (G0. Spleen cells or cultured effector cells were incubated 
at  1 ×  107/ml of a  1:1,000  dilution of ascitic fluid for 30 min on ice, washed once, and then 
incubated for 45 min at 37°G with the same volume of a  1:10 dilution of rabbit C', selected for 
low natural cytotoxicity on BALB/c thymocytes. After two washings, responder and effector 
cells were assayed on the basis of the number of initial responder cells treated. 
Results 
Pn'ma~y and  Secondary NZB  anti-BALB/c  Responses.  NZB  mice  differ  from  H-2- 
identical BALB/c and DBA/2 mice in the Tla region by the serologically defined TL 
and Qa-1  antigens (6) and by Qed-1, a  target antigen for unrestricted T  cell killing 
(4).  Because Qed-1  stimulates primary cytotoxic responses in vitro in several strain 
combinations (4), it is likely to be involved in a  primary NZB anti-BALB/c response. 
Table II confirms that normal NZB spleen cells from all four sublines tested responded 
in  nearly  all  experiments  to  stimulation  with  BALB/c.  Contrary  to  the  claim  of 
TABLE  II 
Specificity of Primary In Vitro Responses of NZB Lymphocytes against H-2-Compatible BALB/c 
Stimulators 
Responder  Stimulator  Experi- 
ment 
Percent 51Cr release from target ceils* 
BALB/c  BALB.B  BALB.K  C57BL/6  B6. T/a  =  C58/J  NZB/BINJ 
d,b~  b,b  k,b  b,b  b,a  k,a  d,a 
NZB/BINJ  NZB/BINJ  l  7.9  2.9  --§  7.1  2.6  --  8.9 
NZB/BIN.J  NZB/BINJ  2  --0.5  0.6  --  0.8  1.4  --3.6  0,8 
NZB/CrBom  NZB/GrBom  4  2.0  --  5,0  --4.0  --  4.1  2.4 
NZB/BINJ  BAI,B/c  1  46.4  47.4  --  49.7  12.3  --  6.9 
NZB/IIINJ  BALB/c  2  24.8  29.6  --  ISA)  1.2  5.6  2.6 
NZB/BIN[J  BAI,B/c  3  25.4  16.8  --  322  8. I  10.6  6.2 
NZB/GrBom  BALB/c  3  28.7  22.4  --  22.7  5.4  6.4  8.4 
NZB/GrBom  BALB/c  4  22.4  --  17.8  13.3  --  8.2  5.2 
NZB/FIill  BALB/c  3  27.9  31.7  --  25.3  4.7  5.9  11.5 
NZB/Ffill  BALB/c  4  13.2  --  15.1  -2.4  --  -0.4  1.3 
NZB/Icr  BALB/c  4  26.9  --  26.8  13.4  --  0.2  7.9 
NZB/BINJ  C57BL/6  l  10.9  68.5  --  60.3  67.1  --  4.1 
NZB/BINJ  C57BL/6  2  9.2  48.6  --  41.9  40.8  --  12.0 
NZB/BINJ  C57BL/6  3  13.6  62.6  --  55.0  51.9  35.3  4.9 
* LPS-stimulated spleen cells,  30 initial responder cells/target cell, 
$ H-2 and Qed-I type. 
§ --, not done. 1586  MATERNALLY  TRANSMITTED  ANTIGEN 
Theofilopoulos et al. (3), we found no evidence that this response was H-2 restricted: 
there was no significant difference between the lysis of BALB/c (H-2  a) and BALB.B 
(H-2  b)  or BALB.K (H-2  k)  target cells (P >  0.05;  Wilcoxon's signed rank test). Nor 
did the response appear specific for BALB minor histoeompatibility antigens, because 
C57BL/6 target cells were lysed equally well. B6. Tla  a target cells, on the other hand, 
which differ from C57BL/6 only in the Tla region where they share Qed-1  a with NZB, 
and  other  Qed-1  a  target  cells  (see  also  Fig.  1)  were not  lysed, confirming that  the 
response is specific for Qed-1  (4, 5). 
When the NZB lymphocytes were primed in vivo with BALB/c and then restimu- 
lated in vitro, a strong cytotoxic response was seen on all target cells tested, irrespective 
of their H-2 or Qed-1 type (Fig.  1). The response was specific because NZB target cells 
were  not  killed.  It  required  restimulation  with  BALB/c  because  primed  NZB  re- 
sponder cells cultured with syngeneic irradiated cells displayed no cytotoxic activity. 
With  cold target  inhibition  of the killing of appropriately selected  radiolabeled 
target cells, it is possible to distinguish the specificities involved in complex cytotoxic 
responses  (4,  8).  Fig.  2  shows  that three major specificities can be identified in  the 
secondary NZB anti-BALB/c cytotoxic response. The lysis of every target is inhibited 
by BALB/c, which carries all the stimulating antigens, but not by NZB/BINJ, which 
itself is not lysed. The lysis of BALB.B is inhibited by the three Qed-1 b target cells, 
but not clearly by any Qed-1 ~ target. There must be an H-2a-restricted component in 
the response because BALB.B (H-2  b) does not inhibit the lysis of BALB/c (H-2a), and 
because the lysis of (SJL ×  NZB)F1 is inhibited by the FI cells (/-/-2  ~ ×  //-2  a) but not 
to the same extent by SJL (H-2~). The B6. Tla  a target cells (H-2  b,  Qedol  a) define the 
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FIe. 2.  Inhibition of lysis by NZB/CrBom effector  cells primed and restimulated with BALB/c. 
Target cells were LPS-stimulated spleen cells. 
last specificity. Every target cell that was killed in Fig.  1 inhibits the lysis of B6. Tla  a, 
showing that they all share the antigen detected here. We shall call this antigen Mta. 
Strain Distribution  of Mta.  Table I  lists the strains that have been typed for Mta, 
usually by cold target inhibition of lysis but occasionally, where Qed-l b-specific or H- 
2d-restricted lysis could be excluded, by direct lysis. The only Mta- non-NZB strain 
found to date is the non-inbred NMRI strain. The 26 strains found positive for Mta 
included 9 different H-2 haplotypes and about  14 different non-H-2 backgrounds, of 
which at  least 8  can be considered unrelated  (11).  The antigen was  found in mice 
from six different sources, and was detected in experiments performed in Basel as well 
as in Philadelphia, making it unlikely that the antigen is the result of an infection in 
the holding facilities which spread to all incoming mice. 
Mta was found even among NZB mice. Cold target inhibition tests showed that the 
NZB  substrain  maintained  at  the  Institut  f'tir  Biologiseh-Medizinische Forschung, 
Fiillinsdorf, Switzerland (provisionally designated NZB/FiiI1) was Mta  +. This line has 
been developed from breeding pairs  provided in  1978  by Dr.  M.  Potter, National 
Cancer Institute, Bethesda, Md. Dr. Potter's line (NZB/BIPt) originated around 1968 
from breeders obtained from Dr.  L.  W.  Law,  National Cancer Institute.  Table III 
shows  that  although primed  NZB/CrBom anti-BALB/c effector cells do not  react 
with target ceils from NZB mice obtained from The Jackson Laboratory, Bar Harbor, 
Maine or from the Institute for Cancer Research, they kill both NZB/Fiill and NZB/ 
BIPt target cells. 
By immunizing NZB/CrBom  mice with  spleen  cells  from  NZB/Fiill  mice,  it  is 
possible to generate Mta-specifie CTL in the absence of a  response against  Qed-1 b, 
making direct Mta typing easier (Table III). However, some part of the response must 
be directed against  minor histoeompatibility antigens  (presumably H-2  d restricted), 
because the lysis of NZB/Fiill target cells is not inhibited by excess BALB/c targets 
that share Mta (data not shown). As expected, immunization of NZB/Fiill mice with 
BALB/c cells  induces  a  Qed-lb-specific response  (C57BL/6 vs.  B6.Tla  a  targets  in 
Table III) and a  response against  minor histocompatibility antigens  (lysis of NZB/ 
BINJ  targets),  but  no  response  against  Mta  (failure  to  lyse  B6. Tla"  and  C58/J). 1588  MATERNALLY TRANSMITTED  ANTIGEN 
TABLE III 
Comparison of NZB Substrains 
Stimulator 
Experi-  Respender  NZB substrain 
mere 
In vivo  In vitro 
Percent SlCr release* 
BALB/c  C578L/6  Bf,Tta ~  C58/J 
CrBom  BINJ  tcr  Frill  B1Pt  d,b  b,b  b,a  k,a 
d,a'~  d,a  d,a  d,a  d,a 
1  NZB/CrBom  BALB/c  IX§  BALB/c  5.1  -0.6  8.3  58.0  --II  72.9  55.6  47.1  45.9 
2  NZB/CrBom  BALB/c  1×§  BALB/c  3.6  --  --  61.7  49.6  --  --  --  56.2 
1  NZB/CrBom  NZB/FIill 2X  NZB/Fiill  -3.9  -1.5  7.7  69.2  --  68.7  49.7  49.0  44.0 
3  NZB/FIill  BALB/c  lX  BALB/c  --  51.9  --  84,1  68.2  6.3  10.3 
1  NZB/Fiill  NZB/CrBom  2×  NZB/CrBom  66.4  71,2  62.3  13.7  --  65,9  84  5,4  18.0 
2  NZB/FIill  NZB/CrBom  2×  NZB/CrBom  60,6  --  --  4.6  5.4  --  -- 
* LPS-stimulated  spleen cells; 30 initial responder cells/target  cell. 
:~ H,2 and Qed-I types. 
§  1×, once; 2X, twice, 
I1--, not done. 
TABLE  IV 
Nature of the NZB Lymphocytes Responding In Vitro to Stimulation with BALB/c Spleen Cells 
Treatment after 
Responder  Treatment before culture 
culture 
Percent  5XCr-release from target ceils* from 
Experiment  1  Experiment  2 
BALB/c  B6.Tla*  BALB/c  C58/J 
NZB/CRIlom-I °:~ 
NZB normal  (6 X  IO  s) 
NZB  normal  (3  x  10S)  + 
NZB-I °  (3 ×  10S) 
NZB  normal  (3  X  l0  s)  + 
NZB-I °  (1,8 ×  l0  n) 
--  --  66.2  40.3  74.2 
Nylon wool  purified§  None  64.8  33.6  70.9 
Anti-lg cohmm  passed  None  --¶  72.8 
Ami-Thy-l.2  +  C' (3 ×  I(1")11  N(me  -3.8  -2.7 
C' alone (3 x  10n)  None  55,4  282  -- 
--  None  39.5  0,7  -- 
--  None  58.3  38.7  -- 
Anti-Thy-l.2  +  C'  None  40.5  -12,5  -- 
NZB/CrBom-1 °  --  Anti-Thy-l,2  +  C'  -2.4  -3.2  3.4 
NZB/CrBom-1 °  --  C' alone  63.8  43.3  80.2 
(~)A) 
522 
492 
m 
-2.5 
61.0 
* LPS-stimulated  spleen cells; 30 initial responder cells/target cell. 
:~ 1% primed with BALB/c  in vivo. 
§  1.2% lg  + cells after passage over nylon wool, 9,6% after passage  through anti-lg column in experiment  2. 
U  Equivalents based on number of cells initially treated. 
¶ --, not done. 
Immunization of NZB/FiJll  with  NZB/Bom  generates  an  H-2d-restricted  response 
against  minor histocompatibility  antigens  (lysis of BALB/c,  not BALB.B  [data not 
shown]; the lysis of C58/J  was not reproduced in four other experiments).  The data 
in Table III suggest that NZB/Fiill differs little, if at all, from NZB/BIPt.  Cold target 
cells from both of these substrains have been shown to inhibit  Mta-specific  cytotox- 
icity,  although on occasion less efficiently than cells  from other strains  (an example 
occurs in Table V). 
Nature of the Responding  CelL  The cell  that  responds to Mta  is a  T  cell.  It  passes 
through  nylon wool or rabbit  anti-mouse  Ig columns and  is  killed  by  monoclonal 
anti-Thy-l.2  antibodies and C', both before and after culture (Table IV). It requires 
priming,  because  normal NZB  ceils  mixed  with  T-depleted  primed  NZB  cells  and 
stimulated with BALB/c could respond to Qed-1 b, but not to Mta. K.  FISCHER LINDAHL, M.  BOCCHIERI, AND R.  RIBLET  1589 
Distribution of Mta on Lymphoid Cells.  In all the above experiments,  LPS-stimulated 
spleen cells were used as targets. As shown in Fig. 3, similar responses were obtained 
on phytohemagglutinin (PHA)- or ConA-stimulated lymphoblasts. Mta could also be 
demonstrated  on  fresh,  normal  spleen  cells,  T  cells  as  well  as  B  cells.  The  lower 
plateau levels of lysis are characteristic of normal spleen cells as targets, whatever the 
effector cell  specificity  (4).  Mta was  also detectable  by direct  lysis on a  number of 
cloned C57BL/6 T  helper cell lines (described in [12]). 
Some frequently used tumor target cell lines have also been typed for Mta by cold 
target  inhibition  (Table  V)  and  direct  lysis  (data  not  shown).  All  were  strongly 
positive,  even  those  with  very  low  levels  of  H-2  antigens  (K.  Fischer  Lindahl. 
Unpublished  observations.). 
Genetics  of Mta.  To  determine  whether  Mta,  like  most  other  target  antigens  for 
unrestricted T  cell killing, was encoded by genes linked to the H-2 complex, we typed 
the existing recombinant inbred  (RI) strains derived from crosses of NZB/Icr (Mta-, 
H-2  a)  and  C58/J  (Mta ÷, H-2k).  The results  show that  five strains  were  Mta-  and 
eight strains Mta ÷ (Fig. 4). The H-2 typing, done by cold target inhibition of killing 
in the same experiments as the Mta typing, agrees with previous results (7), except for 
NXS-9.  The previously reported  subline  of this  strain  is  extinct,  and  the  surviving 
subline  is H-2 k. The distribution  of Mta among the RI lines showed no association 
with H-2 (among the positive mice, four were H-2 k and  four were H-2a;  among the 
negatives,  three were H-2 k and two were H-2  a) or with any other marker for which 
these mice have been typed (7). 2 On the other hand, the strain distribution pattern of 
Mta is perfectly correlated with the construction of the original matings from which 
the strains were derived.  RI 3, 4, and 5 were derived from Fz mice from the cross (N9 
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FIG. 3.  Lysis  of  C58/J target cells by NZB/CrBom effector cells immunized twice and restimulated 
in vitro with NZB/Fiill spleen cells (--) and by C3H/HeJ anti-B10.A(5R) (---); the latter effector 
cells gave 53% specific 51Or-release fi'om C57BL/6 LPS blasts at 30 initial responders/target cell. 
2 Bocchieri, M., R. J. Riblet, and J. B. Smith. Autologous mixed lymphocyte reactions in NZB mice: 
analysis in  recombinant  inbred  lines shows a  T  cell defect unrelated  to  auto-antibody  production. 
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TABLE  g 
Presence of Mta on  Various Tumor Cell Lines 
Inhibitor 
Anti-Mta*  Anti-H-2  ~* 
B6.Tla'~.  C3H/Tif:~  C58/J:~  C3H/Tif~ 
Experi-  Experi-  Experi-  Experi- 
ment 1  ment 2  ment  1  ment 2 
None  39.0§  46.5  73.3  47.2 
NZB/CrBom  32.5  44.7  71.3  39.6 
NZB/Fiill  18.3  8.5  72.9  40.1 
BALB/c  9.2  9.5  72.7  39.1 
B6. Tla  a  1.6  -II  69.3  -- 
C3H/Tif  --  4.3  --  5.8 
C58/J  8.2  --  31.4  -- 
P815  2.2  --  57,8  -- 
EL4  1.4  --  63.3  -- 
AKR-A  0.4  5.7  49.8  28.3 
YAC-1  1.7  1.3  61.1  37.9 
* Effector cells:  Anti-Mta:  NZB/CrBom primed and restimulated with BALB/c in 
experiment 1, with NZB/FIill in experiment 2. Anti-H-2k:  NZB/Fiill anti-C58/J in 
experiment 1, BALB/c anti-C3H/Tif in experiment 2. 
~: Target cells:  LPS-stimulated spleen cells. 
§ Percent 51Cr release. 
II--, not done. 
X 8¢~)F12 X (N2 X 8d) Fxd, strains RI 6 and 9 from (N X 8) X (8 x  N), strains RI 13 
and  15 from (8 X N)  X  (8 X N), and strains RI  16-20 from (8 X N)  X  (N X 8); i.e., 
the  maternal  line  of descent  the  Mta-  strains  is  derived  from  NZB,  whereas  the 
maternal  line  of descent  of the  Mta  +  strains  is  derived  from  C58.  These  results 
forcefully suggest a maternal effect on the expression of Mta, and this was tested on 
reciprocal F1 hybrids between Mta-  (NZB)  and Mta  + (BALB/c and C58/J)  strains 
(Fig. 5). Although the cells from F1 hybrids of reciprocal crosses inhibited H-2d-specific 
cytotoxicity equally well, only those derived from an Mta  + mother inhibited Mta- 
specific lysis.  F1 hybrids derived from a  negative mother were negative. The female 
reciprocal F1 hybrids between NZB and BALB/c are particularly informative, because 
these mice should be genotypically identical. We also included cold target cells from 
very old  (>2 yr)  NZB/Icr mice in these experiments. Plainly, Mta  is not acquired 
with age (Fig. 5). 
Backcrossing Mta  + (A.CA9  X  NZBd)Fx hybrids to NZB  females produced Mta- 
offspring, whereas backcrossing to NZB males yielded Mta  + offspring (Fig. 6). The 
results  for all  backcross animals  are  summarized  in  Table VI.  The  probability of 
getting the observed or a  more extreme distribution of the H-2  ~ haplotype is 0.247 
(Fisher's exact test); the probability of getting the observed distribution of Mta by 
chance alone is  1.9 X  10  -7. 
Discussion 
Our experiments serve to define a new target antigen for unrestricted T  cell killing. 
The antigen,  termed Mta  (for maternally transmitted  antigen),  is carried by most Kilter: 
Target: 
Inhibitor  H-2 
None 
BALB/c  d 
NZB/Icr  d 
C3H.SW  b 
C3HIHeJ  k 
C58/J  k 
SJL  S 
NX8  RI  3  k 
4  k 
5  d 
6  d 
9  k 
13a  k 
13b  k 
15  d 
16  k 
17  k 
18  d 
19  d 
20  d 
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FIG. 4.  Typing of NX8  recombinant  inbred strains by cold target inhibition of lysis.  All target 
cells were ConA-stimulated spleen cells. The effector cells were NZB/Icr primed and restimulated 
by BALB/c (anti-Mta), NX8-17 anti-BALB/c (anti-H-2a), and NX8-20 anti-C3H/HeJ (anti-H-2k). 
mouse strains  tested except for some NZB substrains  and  non-inbred NMRI mice. 
The antigen is  displayed by all  lymphoid target cells and  a  number of tumor cell 
lines. Mta did not segregate with H-2 or any other marker; rather, the rule, to which 
we  found no exception, is  that  Mta  + females bear positive offspring whatever the 
phenotype of the  male  may  be,  and  Mta-  mothers  bear  negative  offspring.  The 
phenotypes of NX8 recombinant inbred strains (Fig. 4) and of backcross mice (Fig. 6 
and  Table VI)  make sex-linkage of Mta  unlikely, and  the  typing of reciprocal F1 
hybrids (Fig. 5) rules it out. 
Two alternatives remain. Perhaps all mice have the genetic information to produce 
Mta,  and  there is an epigenetic transmission  from negative mothers of a  principle 
that  prevents expression of Mta  for the lifetime of their offspring. It is not easy to 
envisage such a mechanism and, even though our experiments to date do not rule it 
out, we favor the alternative, a maternally transmitted genetic element coding for the 
antigen (Mta). 
Such a maternally transmitted antigen might be passed on via the egg, through the 
placenta, or in the milk; it is likely to be a virus. Milk-transmitted mammary tumor 
virus is a well-established precedent (13); moreover, it has been reported to give rise 
to unrestricted T  cell killing  (14).  Foster-nursing of hysterectomy-derived mice by 
NZB/Icr or BALB/c  mothers  gave  no evidence that  Mta  is  milk-transmitted  (K. 
Fischer  Lindahl,  M.  Bocchieri,  and  R.  Riblet.  Manuscript  in  preparation.),  and 1592  MATERNALLY  TRANSMITTED ANTIGEN 
Killer: 
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SJL 
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FIG.  5.  Mta typing of reciprocal F] hybrids; results of two experiments using LPS- (---) and ConA- 
(--)  stimulated target cells from one or two  donors. Effector cells were NZB/Icr  primed and 
restimulated with BALB/c  (anti-Mta) and N × 8-16 (---) or N × 8-17 (--) anti-BALB/c  (anti-H- 
2't). The donors of the NZB/Icr cold target cells were >2 yr old. 
embryo-transfer  experiments  are  now  required  to  distinguish  between  the  other 
possibilities. 
There  is  no evidence  of horizontal  transmission  of Mta.  Even  very old  NZB/Icr 
mice reared  in an environment  of positive strains stayed negative  (Fig.  5);  the Mta + 
NZB/BIPt  substrain  and  its  derivative  NZB/Fiill  differ  from other  NZB  substrains 
by additional  antigens,  suggesting  a  genetic  contamination  of the line  (Table II1).  If 
NZB  mice  were  resistant  to  a  ubiquitous  virus  because  of  a  lack  of receptors  or 
interference  by genomic viruses, one would expect  backcrosses to NZB to yield some 
resistant  progeny.  However,  in  the  first  generation  we  have  studied,  12  out  of  12 
(A.CA ×  NZB)Fx  ×  NZB mice were Mta +. 
Mta  is  the  first  genetically  analyzed  target  antigen  for unrestricted  T  cell  killing 
that  is  not  evidently  linked  to  the  major  histocompatibility  complex  (4,  8,  15).  Its 
demonstration  does  not  require  prolonged  assays  (14),  and  it  is  detected  under  the 
same  conditions  as  H-2-restricted  responses.  We  saw  no  primary  responses  against 
Mta,  but  a  single  immunization  in  vivo induced  strong  responsiveness,  which  does 
not require a  simultaneous  response against Qed-1 b. Responsiveness  does not depend 
on the H-2  d haplotype:  cells  from Mta-  NX8-3  and NX8-4  (H-2 k)  mice primed and 
restimulated with C3H/HeJ cells responded to Mta (K. Fischer Lindahl, M. Bocchieri, 
and R. Riblet.  Unpublished  observations.). 
Mta shows no relationship  to autoimmunity.  The. strain distribution pattern of any 
of several autoimmune traits among the NX8 RI strains does not correlate with Mta7 
Mta-  NMRI  mice are bred for their health  and vigor, whereas the Mta + NZB/BIPt Inhibitor 
None 
NZB/Bom 
C58/J 
SJL 
A.CA 
(A.CA  x  NZB/Bom)FI 
NZBx(A.CAxNZB)  NO.  1 
NO.  2 
No.  3 
No.  4 
(A.CAxNZB)xNZB  No.  1 
No.  2 
No.  3 
No.  4 
K.  FISCHER  LINDAHL,  M.  BOCCHIERI,  AND  R.  RIBLET 
Effector:  Anti-Mta 
Target:  SJL 
Anti-H-2 
A.CA 
51 
%  Cr-release 
0  20  40  60  0  20 
i  i  l  i 
l 
I 
I 
/ 
l 
1593 
f 
40 
| 
Fro.  6.  Typing of first generation backcrosses of (A.CA X NZB/CrBom) F1 to NZB/CrBom. Target 
cells were LPS-stimulated spleen cells and effector cells were NZB/CrBom primed and restimulated 
with BALB/c (anti-Mta) and BALB/c anti-A.CA (anti-H-2f). N  x  (A X N) No. 2 and 3 and (A X 
N) x  N  No. 4 were considered positive for H-2  t. The (A X N)F1 was the father ofthe N  X (A X N) 
backcross mice. All backcross mice were males. 
TABLE VI 
Mta and H-2 Typing ofF#st Generation Backcrosses of (A.CA  X  NZB/CrBom)F1 to NZB/CrBom 
A.  B, 
Cross  Mta  +  Mta-  Total  Cross  H-2  t+  H-2  t-  Total 
N  X  (A X N)*  0  13  13  N  X (A X N)  6  6  1211 
(A x  N) X N~c  12  0  12  (A X IN') X N  3  8  1 ll[ 
Totals  12  13  25  Totals  9  14  23 
P =  1.9 x  10-7§  P =  0.247§ 
A:  Inhibition  of lysis of SJL  and  C58/J  target  cells by  NZB/CrBom  primed  and restimulated with 
BALB/c. B: Inhibition of lysis of A.CA by BALB/c anti-A.CA effector cells. 
*39+  103. 
~:89+4d. 
§ Fisher's exact test. 
II The results did not permit unequivocal typing of one animal in either group. The P values for the four 
possible allocations ranged from 0.144 to 0.404. 
strain  is prone to various lymphoproliferative disorders  (M.  Potter.  Personal com- 
munication.).  Finally, a  study of reciprocal FI hybrids between  NZB  and  DBA/2 
showed no difference in their ability to produce autoantibodies (16). 
Summary 
A  new target antigen for unrestricted killing was defined by NZB T  lymphocytes 
which  were  immunized  and  restimulated  with  H-2-identical  BALB/c spleen cells. 1594  MATERNALLY TRANSMITTED ANTIGEN 
These effector cells killed nearly all target cells tested,  irrespective of their H-2 type, 
but  did  not  kill  NZB  target  cells.  The  response  was  shown  to  have  three  major 
components:  unrestricted  killing  specific  for Qed-1 b,  H-2d-restrieted  killing  specific 
for  minor  histocompatibility  antigens,  and  unrestricted  killing  specific  for  a  new 
antigen, Mta. Mta is present on normal and mitogen-stimulated T  and B lymphocytes 
and  on  several  tumor  lines.  It  was  found  on  cells  from  26  mouse  strains  tested, 
including two substrams of NZB, representing 9 different H-2 types and  14 different 
non-Ho2 backgrounds. Analysis of the NX8 recombinant  inbred  lines  (derived from 
Mta- NZB/Icr and Mta + C58/J parents)  suggested that Mta is maternally transmit- 
ted.  This was confirmed by typing of reciprocal FI hybrids and backcrosses between 
positive and  negative strains:  Mta + females bear Mta + offspring and  Mta-  females 
Mta- offspring, irrespective of the phenotype of the males. 
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